The DOI matches its Crossref record; 225 of the 225 references it cites were found in a registry or an index.
Nanotechnology for Cancer Therapy Based on Chemotherapy
Open accessAbstract
Chemotherapy has been widely applied in clinics. However, the therapeutic potential of chemotherapy against cancer is seriously dissatisfactory due to the nonspecific drug distribution, multidrug resistance (MDR) and the heterogeneity of cancer. Therefore, combinational therapy based on chemotherapy mediated by nanotechnology, has been the trend in clinical research at present, which can result in a remarkably increased therapeutic efficiency with few side effects to normal tissues. Moreover, to achieve the accurate pre-diagnosis and real-time monitoring for tumor, the research of nano-theranostics, which integrates diagnosis with treatment process, is a promising field in cancer treatment. In this review, the recent studies on combinational therapy based on chemotherapy will be systematically discussed. Furthermore, as a current trend in cancer treatment, advance in theranostic nanoparticles based on chemotherapy will be exemplified briefly. Finally, the present challenges and improvement tips will be presented in combination therapy and nano-theranostics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Liu, B., Li, C., Chen, G., Liu, B., Deng, X., Wei, Y., Xia, J., Xing, B., Ma, P., & Lin, J. (2017) · Advanced Science · doi:10.1002/advs.201600540 · Cited by 316
RetractedZhou, M., Zhao, J., Tian, M., Song, S., Zhang, R., Gupta, S. K., Tan, D., Shen, H., Mauro Ferrari, B., & Li, C. (2015) · Nanoscale · doi:10.1039/c5nr04587h · Cited by 87
RetractedHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
The DNA-damage response in human biology and disease
Jackson, S. P., & Bartek, J. (2009) · Nature · doi:10.1038/nature08467 · Cited by 6,092
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664 · cited 1×
“Liposomes, spherical vesicles composed of lipid bilayer with the ability to diffuse across cell membranes easily to deliver agents to cells, can carry hydrophilic and/or hydrophobic therapeutic and diagnostic agents in the inner aqueous core of the structure and/or in the trans-membrane section [12,13].”
BackgroundNanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Fang, J., Nakamura, H., & Maeda, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,559
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348
Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C. J., Jamieson, C. H. M., Jones, D. L., Visvader, J., Weissman, I. L., & Wahl, G. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3126 · Cited by 3,051
Tumour heterogeneity and cancer cell plasticity
Meacham, C. E., & Morrison, S. J. (2013) · Nature · doi:10.1038/nature12624 · Cited by 2,446
Tumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Si, M.-L., Zhu, S., Wu, H., Lu, Z., Wu, F., & Mo, Y.-Y. (2007) · Oncogene · doi:10.1038/sj.onc.1210083 · Cited by 1,600
Douillard, J.-Y., Rosell, R., De Lena, M., Carpagnano, F., Ramlau, R., Gonzáles-Larriba, J. L., Grodzki, T., Pereira, J. R., Le Groumellec, A., Lorusso, V., et al. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70804-x · Cited by 1,573
Nishida, N., Yano, H., Nishida, T., Kamura, T., & Kojiro, M. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.3.213 · Cited by 1,434
Diverse Applications of Nanomedicine
Pelaz, B., Alexiou, C., Alvarez-Puebla, R. A., Alves, F., Andrews, A. M., Ashraf, S., Balogh, L. P., Ballerini, L., Bestetti, A., Brendel, C., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b06040 · Cited by 1,350
Lombardo, L. J., Lee, F. Y., Chen, P., Norris, D., Barrish, J. C., Behnia, K., Castaneda, S., Cornelius, L. A. M., Das, J., Doweyko, A. M., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049486a · Cited by 1,297
Bio-inspired, bioengineered and biomimetic drug delivery carriers
Yoo, J.-W., Irvine, D. J., Discher, D. E., & Mitragotri, S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3499 · Cited by 1,236
Zong, W.-X., & Thompson, C. B. (2006) · Genes & Development · doi:10.1101/gad.1376506 · Cited by 917
State of the art in the delivery of photosensitizers for photodynamic therapy
Konan, Y. N., Gurny, R., & Allémann, E. (2002) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/s1011-1344(01)00267-6 · Cited by 906
Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide
Zhang, W., Guo, Z., Huang, D., Liu, Z., Guo, X., & Zhong, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.071 · Cited by 891
A New Era for Cancer Treatment: Gold‐Nanoparticle‐Mediated Thermal Therapies
Kennedy, L. C., Bickford, L. R., Lewinski, N. A., Coughlin, A. J., Hu, Y., Day, E. S., West, J. L., & Drezek, R. A. (2011) · Small · doi:10.1002/smll.201000134 · Cited by 885
Progress of drug-loaded polymeric micelles into clinical studies
Cabral, H., & Kataoka, K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.042 · Cited by 837 · cited 1×
“The pH-triggered polymeric micellar nanomedicines loading STS and the cytotoxic agent epirubicin (Epi) could simultaneously release both drugs at acidic endosomal pH, overcome the MDR and attain coordinated therapeutic effects to eradicate both CSCs and cancer cells [73,74].”
BackgroundRNA interference in the clinic: challenges and future directions
Pecot, C. V., Calin, G. A., Coleman, R. L., Lopez-Berestein, G., & Sood, A. K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2966 · Cited by 820
Zheng, M., Yue, C., Ma, Y., Gong, P., Zhao, P., Zheng, C., Sheng, Z., Zhang, P., Wang, Z., & Cai, L. (2013) · ACS Nano · doi:10.1021/nn400334y · Cited by 795
Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches
Wu, Q., Yang, Z., Nie, Y., Shi, Y., & Fan, D. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.03.013 · Cited by 776
Self-citationHe, C., Duan, X., Guo, N., Chan, C., Poon, C., Weichselbaum, R. R., & Lin, W. (2016) · Nature Communications · doi:10.1038/ncomms12499 · Cited by 754
Enzyme-responsive polymeric assemblies, nanoparticles and hydrogels
Hu, J., Zhang, G., & Liu, S. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35103j · Cited by 722
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
Libutti, S. K., Paciotti, G. F., Byrnes, A. A., Alexander, H. R., Gannon, W. E., Walker, M., Seidel, G. D., Yuldasheva, N., & Tamarkin, L. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0978 · Cited by 710
Cell Death Pathways in Photodynamic Therapy of Cancer
Mroz, P., Yaroslavsky, A., Kharkwal, G. B., & Hamblin, M. R. (2011) · Cancers · doi:10.3390/cancers3022516 · Cited by 704
Cancer nanomedicine: from targeted delivery to combination therapy
Xu, X., Ho, W., Zhang, X., Bertrand, N., & Farokhzad, O. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.01.001 · Cited by 693
Chen, A. M., Zhang, M., Wei, D., Stueber, D., Taratula, O., Minko, T., & He, H. (2009) · Small · doi:10.1002/smll.200900621 · Cited by 671
Meng, H., Mai, W. X., Zhang, H., Xue, M., Xia, T., Lin, S., Wang, X., Zhao, Y., Ji, Z., Zink, J. I., et al. (2013) · ACS Nano · doi:10.1021/nn3044066 · Cited by 575
Gold nanoparticles: opportunities and challenges in nanomedicine
Arvizo, R., Bhattacharya, R., & Mukherjee, P. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425241003777010 · Cited by 538
A Review of Clinical Translation of Inorganic Nanoparticles
Anselmo, A. C., & Mitragotri, S. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9780-2 · Cited by 509
Photodynamic therapy (PDT) of cancer: from local to systemic treatment
Dabrowski, J. M., & Arnaut, L. G. (2015) · Photochemical & Photobiological Sciences · doi:10.1039/c5pp00132c · Cited by 501
Targeted therapy using nanotechnology: focus on cancer
Sechi, M., Sanna, V., & Pala, N. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s36654 · Cited by 493
Cancer Nanomedicine: From Drug Delivery to Imaging
Chow, E. K.-H., & Ho, D. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005872 · Cited by 491
Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine
Zhang, X.-Q., Xu, X., Bertrand, N., Pridgen, E., Swami, A., & Farokhzad, O. C. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.005 · Cited by 487
Paclitaxel-Functionalized Gold Nanoparticles
Gibson, J. D., Khanal, B. P., & Zubarev, E. R. (2007) · Journal of the American Chemical Society · doi:10.1021/ja075181k · Cited by 484
Paciotti, G. F., Kingston, D. G. I., & Tamarkin, L. (2006) · Drug Development Research · doi:10.1002/ddr.20066 · Cited by 484
Wang, C., Xu, H., Liang, C., Liu, Y., Li, Z., Yang, G., Cheng, L., Li, Y., & Liu, Z. (2013) · ACS Nano · doi:10.1021/nn4017179 · Cited by 483
Robert, N., Leyland-Jones, B., Asmar, L., Belt, R., Ilegbodu, D., Loesch, D., Raju, R., Valentine, E., Sayre, R., Cobleigh, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.1764 · Cited by 479
Li, J., Huo, M., Wang, J., Zhou, J., Mohammad, J. M., Zhang, Y., Zhu, Q., Waddad, A. Y., & Zhang, Q. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.022 · Cited by 468
Shu, D., Shu, Y., Haque, F., Abdelmawla, S., & Guo, P. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.105 · Cited by 435
Advance in Photosensitizers and Light Delivery for Photodynamic Therapy
Yoon, I., Li, J. Z., & Shim, Y. K. (2013) · Clinical Endoscopy · doi:10.5946/ce.2013.46.1.7 · Cited by 425
Kim, H., Lee, D., Kim, J., Kim, T.-I., & Kim, W. J. (2013) · ACS Nano · doi:10.1021/nn403096s · Cited by 420
Molecular mechanisms for tumour resistance to chemotherapy
Pan, S., Li, Z., He, Z., Qiu, J., & Zhou, S. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12581 · Cited by 401
Lu, D., Choi, M. Y., Yu, J., Castro, J. E., Kipps, T. J., & Carson, D. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110431108 · Cited by 395
Nanoparticles for combination drug therapy
Ma, L., Kohli, M., & Smith, A. (2013) · ACS Nano · doi:10.1021/nn405674m · Cited by 367
Prodrug-based nanoparticulate drug delivery strategies for cancer therapy
Luo, C., Sun, J., Sun, B., & He, Z. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.09.008 · Cited by 352
Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor.
Henderson, B. W., & Fingar, V. H. (1987) · PubMed · Cited by 342
Chen, Q., Wang, X., Wang, C., Feng, L., Li, Y., & Liu, Z. (2015) · ACS Nano · doi:10.1021/acsnano.5b00640 · Cited by 341
Development of Therapeutic Combinations Targeting Major Cancer Signaling Pathways
Yap, T. A., Omlin, A., & de Bono, J. S. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.6418 · Cited by 329
Song, J., Yang, X., Jacobson, O., Lin, L., Huang, P., Niu, G., Ma, Q., & Chen, X. (2015) · ACS Nano · doi:10.1021/acsnano.5b03804 · Cited by 319
Cui, J., Yan, Y., Such, G. K., Liang, K., Ochs, C. J., Postma, A., & Caruso, F. (2012) · Biomacromolecules · doi:10.1021/bm300835r · Cited by 317
Yuan, Y., Liu, J., & Liu, B. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201402189 · Cited by 302
Dong, Z., Gong, H., Gao, M., Zhu, W., Sun, X., Feng, L., Fu, T., Li, Y., & Liu, Z. (2016) · Theranostics · doi:10.7150/thno.14431 · Cited by 296
Singlet Oxygen Production by Peptide-Coated Quantum Dot−Photosensitizer Conjugates
Tsay, J. M., Trzoss, M., Shi, L., Kong, X., Selke, M., Jung, M. E., & Weiss, S. (2007) · Journal of the American Chemical Society · doi:10.1021/ja070713i · Cited by 291
Albumin Carriers for Cancer Theranostics: A Conventional Platform with New Promise
Chen, Q., & Liu, Z. (2016) · Advanced Materials · doi:10.1002/adma.201600038 · Cited by 290
Fingar, V. H., Wieman, T. J., Wiehle, S., & Cerrito, P. B. (1992) · PubMed · Cited by 289
Zeng, J., Zhang, M., Peng, M., Gong, D., & Zhang, X. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201705451 · Cited by 287
A Self‐Assembled Albumin‐Based Nanoprobe for In Vivo Ratiometric Photoacoustic pH Imaging
Chen, Q., Liu, X., Chen, J., Zeng, J., Cheng, Z., & Liu, Z. (2015) · Advanced Materials · doi:10.1002/adma.201503194 · Cited by 286
Werner, M. E., Cummings, N. D., Sethi, M., Wang, E. C., Sukumar, R., Moore, D. T., & Wang, A. Z. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.02.009 · Cited by 267
Mroz, P., Pawlak, A., Satti, M., Lee, H., Wharton, T., Gali, H., Sarna, T., & Hamblin, M. R. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.005 · Cited by 257
Antimicrobial photodynamic therapy: An overview
Koshi, E., Rajesh, S., Philip, K., & Mohan, A. (2011) · Journal of Indian Society of Periodontology · doi:10.4103/0972-124x.92563 · Cited by 255
Song, Q., Yin, Y., Shang, L., Wu, T., Zhang, D., Kong, M., Zhao, Y., He, Y., Tan, S., Guo, Y., et al. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b03186 · Cited by 254
Fan, W., Shen, B., Bu, W., Chen, F., He, Q., Zhao, K., Zhang, S., Zhou, L., Peng, W., Xiao, Q., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.07.024 · Cited by 251
Nanotoxicity: A Key Obstacle to Clinical Translation of siRNA-Based Nanomedicine
Xue, H. Y., Liu, S., & Wong, H. L. (2014) · Nanomedicine · doi:10.2217/nnm.13.204 · Cited by 250
18F Labeled Nanoparticles for in Vivo PET-CT Imaging
Devaraj, N. K., Keliher, E. J., Thurber, G. M., Nahrendorf, M., & Weissleder, R. (2009) · Bioconjugate Chemistry · doi:10.1021/bc8004649 · Cited by 245
Dasatinib: A potent SRC inhibitor in clinical development for the treatment of solid tumors
Araujo, J., & Logothetis, C. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.02.015 · Cited by 244
Liposomes as ‘smart’ pharmaceutical nanocarriers
Sawant, R. R., & Torchilin, V. P. (2010) · Soft Matter · doi:10.1039/b923535n · Cited by 243
Yang, Y.-P., Chien, Y., Chiou, G.-Y., Cherng, J.-Y., Wang, M.-L., Lo, W.-L., Chang, Y.-L., Huang, P.-I., Chen, Y.-W., Shih, Y.-H., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.071 · Cited by 240
Drug Carrier for Photodynamic Cancer Therapy
Debele, T., Peng, S., & Tsai, H.-C. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160922094 · Cited by 239
Cooperative Nanoparticles for Tumor Detection and Photothermally Triggered Drug Delivery
Park, J., von Maltzahn, G., Ong, L. L., Centrone, A., Hatton, T. A., Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2010) · Advanced Materials · doi:10.1002/adma.200902895 · Cited by 238
Shor, A. C., Keschman, E. A., Lee, F. Y., Muro-Cacho, C., Letson, G. D., Trent, J. C., Pledger, W. J., & Jove, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3469 · Cited by 234
Li, W., Peng, J., Tan, L., Wu, J., Shi, K., Qu, Y., Wei, X., & Qian, Z. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.08.016 · Cited by 231
Chen, H., Zhang, X., Dai, S., Ma, Y., Cui, S., Achilefus, S., & Gu, Y. (2013) · Theranostics · doi:10.7150/thno.6630 · Cited by 226
Liu, Y., Qiao, L., Zhang, S., Wan, G., Chen, B., Zhou, P., Zhang, N., & Wang, Y. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.11.010 · Cited by 218
Chen, Q., Li, K., Wen, S., Liu, H., Peng, C., Cai, H., Shen, M., Zhang, G., & Shi, X. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.009 · Cited by 215
You, J., Zhang, R., Xiong, C., Zhong, M., Melancon, M., Gupta, S., Nick, A. M., Sood, A. K., & Li, C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1003 · Cited by 214
Nanoscale theranostics for physical stimulus-responsive cancer therapies
Chen, Q., Ke, H., Dai, Z., & Liu, Z. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.09.018 · Cited by 210
Su, J., Sun, H., Meng, Q., Zhang, P., Yin, Q., & Li, Y. (2017) · Theranostics · doi:10.7150/thno.17259 · Cited by 210
Lv, R., Yang, P., He, F., Gai, S., Yang, G., Dai, Y., Hou, Z., & Lin, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.05.016 · Cited by 208
Chen, Y., Ai, K., Liu, J., Ren, X., Jiang, C., & Lu, L. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.11.010 · Cited by 208
Photodynamic therapy (PDT) for malignant brain tumors – Where do we stand?
Quirk, B. J., Brandal, G., Donlon, S., Vera, J. C., Mang, T. S., Foy, A. B., Lew, S. M., Girotti, A. W., Jogal, S., LaViolette, P. S., et al. (2015) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2015.04.009 · Cited by 206
Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges
Zhou, J., Shum, K.-T., Burnett, J., & Rossi, J. (2013) · Pharmaceuticals · doi:10.3390/ph6010085 · Cited by 205
Nanoparticles for Tumor Targeted Therapies and Their Pharmacokinetics
Wang, J., Sui, M., & Fan, W. (2010) · Current Drug Metabolism · doi:10.2174/138920010791110827 · Cited by 205
Drug and gene delivery using gold nanoparticles
Han, G., Ghosh, P., De, M., & Rotello, V. M. (2007) · NanoBiotechnology · doi:10.1007/s12030-007-0005-3 · Cited by 200
Wan, G., Chen, B., Li, L., Wang, D., Shi, S., Zhang, T., Wang, Y., Zhang, L., & Wang, Y. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2017.11.002 · Cited by 199
Venkatraman, G., Ramya, Shruthilaya, Akila, Ganga, Kumar, S., Yoganathan, Santosham, R., & Ponraju (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s25182 · Cited by 195
Trends of Gold Nanoparticle-based Drug Delivery System in Cancer Therapy
Ajnai, G., Chiu, A., Kan, T., Cheng, C.-C., Tsai, T.-H., & Chang, J. (2014) · Journal of Experimental & Clinical Medicine · doi:10.1016/j.jecm.2014.10.015 · Cited by 194
Morton, S. W., Lee, M. J., Deng, Z. J., Dreaden, E. C., Siouve, E., Shopsowitz, K. E., Shah, N. J., Yaffe, M. B., & Hammond, P. T. (2014) · Science Signaling · doi:10.1126/scisignal.2005261 · Cited by 190
Wu, L., Zou, Y., Deng, C., Cheng, R., Meng, F., & Zhong, Z. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.035 · Cited by 187
Self-citationBiodistribution of TNF-α-Coated Gold Nanoparticles in An In Vivo Model System
Goel, R., Shah, N., Visaria, R., Paciotti, G. F., & Bischof, J. C. (2009) · Nanomedicine · doi:10.2217/nnm.09.21 · Cited by 186
Yue, C., Zhang, C., Alfranca, G., Yang, Y., Jiang, X., Yang, Y., Pan, F., Fuente, J. M. D. L., & Cui, D. (2016) · Theranostics · doi:10.7150/thno.14101 · Cited by 184
Lv, S., Tang, Z., Zhang, D., Song, W., Li, M., Lin, J., Liu, H., & Chen, X. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.09.009 · Cited by 181
Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer
Zeisser-Labouèbe, M., Lange, N., Gurny, R., & Delie, F. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.07.012 · Cited by 180
El-Gogary, R. I., Rubio, N., Wang, J. T.-W., Al-Jamal, W. T., Bourgognon, M., Kafa, H., Naeem, M., Klippstein, R., Abbate, V., Leroux, F., et al. (2014) · ACS Nano · doi:10.1021/nn405155b · Cited by 180
Lee, S., Park, H., & Yoo, K. (2010) · Advanced Materials · doi:10.1002/adma.201001040 · Cited by 177
Gemcitabine: A cytidine analogue active against solid tumors
Hui, Y. F., & Reitz, J. (1997) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/54.2.162 · Cited by 177
Werner, M. E., Karve, S., Sukumar, R., Cummings, N. D., Copp, J. A., Chen, R. C., Zhang, T., & Wang, A. Z. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.067 · Cited by 176
Integrated Hollow Mesoporous Silica Nanoparticles for Target Drug/siRNA Co‐Delivery
Ma, X., Zhao, Y., Ng, K. W., & Zhao, Y. (2013) · Chemistry – A European Journal · doi:10.1002/chem.201302736 · Cited by 176
Construction of homogeneous antibody–drug conjugates using site-selective protein chemistry
Akkapeddi, P., Azizi, S., Freedy, A. M., Cal, P. M. S. D., Góis, P. M. P., & Bernardes, G. J. L. (2016) · Chemical Science · doi:10.1039/c6sc00170j · Cited by 174
Topete, A., Alatorre-Meda, M., Iglesias, P., Villar-Alvarez, E. M., Barbosa, S., Costoya, J. A., Taboada, P., & Mosquera, V. (2014) · ACS Nano · doi:10.1021/nn406425h · Cited by 174
Application of nanotechnology to cancer radiotherapy
Mi, Y., Shao, Z., Vang, J., Kaidar‐Person, O., & Wang, A. Z. (2016) · Cancer Nanotechnology · doi:10.1186/s12645-016-0024-7 · Cited by 174
Sun, R., Liu, Y., Li, S.-Y., Shen, S., Du, X.-J., Xu, C.-F., Cao, Z.-T., Bao, Y., Zhu, Y.-H., Li, Y.-P., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.018 · Cited by 172
Wang, Z., Chen, Z., Liu, Z., Shi, P., Dong, K., Ju, E., Ren, J., & Qu, X. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.08.013 · Cited by 172
Yue, C., Yang, Y., Zhang, C., Alfranca, G., Cheng, S., Ma, L., Liu, Y., Zhi, X., Ni, J., Jiang, W., et al. (2016) · Theranostics · doi:10.7150/thno.15433 · Cited by 169
Kono, K., Ozawa, T., Yoshida, T., Ozaki, F., Ishizaka, Y., Maruyama, K., Kojima, C., Harada, A., & Aoshima, S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.045 · Cited by 167
Blanco, E., Bey, E. A., Dong, Y., Weinberg, B. D., Sutton, D. M., Boothman, D. A., & Gao, J. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.014 · Cited by 165
Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers
Cochrane, D. R., Howe, E. N., Spoelstra, N. S., & Richer, J. K. (2010) · Journal of Oncology · doi:10.1155/2010/821717 · Cited by 162
Wang, X., Chen, Y., Dahmani, F. Z., Yin, L., Zhou, J., & Yao, J. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.053 · Cited by 161
Yan, F., Duan, W., Li, Y.-K., Wu, H., Zhou, Y., Pan, M., Liu, H., Liu, X., & Zheng, H. (2016) · Theranostics · doi:10.7150/thno.14937 · Cited by 160
Self-Monitoring Artificial Red Cells with Sufficient Oxygen Supply for Enhanced Photodynamic Therapy
Luo, Z., Zheng, M., Zhao, P., Chen, Z., Siu, F., Gong, P., Gao, G., Sheng, Z., Zheng, C., Ma, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep23393 · Cited by 159
Zhao, F., Yin, H. Y., & Li, J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.044 · Cited by 158
The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor
Riccioni, R., Dupuis, M. L., Bernabei, M., Petrucci, E., Pasquini, L., Mariani, G., Cianfriglia, M., & Testa, U. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.03.008 · Cited by 149
Paramagnetic nanoparticle T1 and T2 MRI contrast agents
Xu, W., Kattel, K., Park, J. Y., Chang, Y., Kim, T. J., & Lee, G. H. (2012) · Physical Chemistry Chemical Physics · doi:10.1039/c2cp41357d · Cited by 147
Development of Manganese-Based Nanoparticles as Contrast Probes for Magnetic Resonance Imaging
Zhen, Z., & Xie, J. (2012) · Theranostics · doi:10.7150/thno.3448 · Cited by 147
Antitumor Drug Delivery Modulated by A Polymeric Micelle with an Upper Critical Solution Temperature
Li, W., Huang, L., Ying, X., Jian, Y., Hong, Y., Hu, F., & Du, Y. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201411524 · Cited by 147
Chen, H., Li, H., Li, J., Zhu, Z. G., Yin, S., Hao, X., Yao, M., Zheng, S.-S., & Gu, J. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn223 · Cited by 146
GhavamiNejad, A., Samarikhalaj, M., Aguilar, L. E., Park, C. H., & Kim, C. S. (2016) · Scientific Reports · doi:10.1038/srep33594 · Cited by 145
Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer
Zhang, M., Liu, E., Cui, Y., & Huang, Y. (2017) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2017.0054 · Cited by 145
Photothermal nanodrugs: potential of TNF-gold nanospheres for cancer theranostics
Shao, J., Griffin, R. J., Galanzha, E. I., Kim, J.-W., Koonce, N. A., Webber, J. S., Mustafa, T. A., Biris, A. S., Nedosekin, D. A., & Zharov, V. P. (2013) · Scientific Reports · doi:10.1038/srep01293 · Cited by 142
The Advantages of Nanoparticles for PET
Welch, M. J., Hawker, C. J., & Wooley, K. L. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.061846 · Cited by 142
Guo, W., Wang, F., Ding, D., et al. (2017) · Chemistry of Materials · doi:10.1021/acs.chemmater.7b03241 · Cited by 142
Nanodrug Formed by Coassembly of Dual Anticancer Drugs to Inhibit Cancer Cell Drug Resistance
Zhao, Y., Chen, F., Pan, Y., Li, Z., Xue, X., Okeke, C. I., Wang, Y., Li, C., Peng, L., Wang, P. C., et al. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b05347 · Cited by 141
Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy
Lammers, T., Šubr, V., Peschke, P., Kühnlein, R., Hennink, W. E., Ulbrich, K., Kiessling, F. M., Heilmann, M., Debus, J., Huber, P. E., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604561 · Cited by 141
Glasgow, M. D. K., & Chougule, M. B. (2015) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2015.2145 · Cited by 139
Du, X. C., Zhao, C., Zhou, M., Ma, T., Huang, H., Jaroniec, M., Zhang, X., & Qiao, S. (2016) · Small · doi:10.1002/smll.201602592 · Cited by 139
Self-citationKhdair, A., Handa, H., Mao, G., & Panyam, J. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.017 · Cited by 138
Zhang, C.-G., Zhu, W.-J., Liu, Y., Yuan, Z.-Q., Yang, S.-D., Chen, W.-L., Li, J., Zhou, X., Liu, C., & Zhang, X. (2016) · Scientific Reports · doi:10.1038/srep23859 · Cited by 137
Shah, B. P., Pasquale, N. J., De, G., Tan, T., Ma, J., & Lee, K. (2014) · ACS Nano · doi:10.1021/nn503431x · Cited by 137
Tsouris, V., Joo, M. K., Kim, S. H., Kwon, I. C., & Won, Y. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.05.006 · Cited by 133
Su, S., Tian, Y., Li, Y., Ding, Y., Ji, T., Wu, M.-Y., Wu, Y. F., & Nie, G. (2015) · ACS Nano · doi:10.1021/nn505729m · Cited by 132
Ta, T., Convertine, A. J., Reyes, C. R., Stayton, P. S., & Porter, T. M. (2010) · Biomacromolecules · doi:10.1021/bm1004993 · Cited by 130
Cui, D., Zhang, C., Liu, B., Shu, Y., Du, T., Shu, D., Wang, K., Dai, F., Liu, Y., Li, C., et al. (2015) · Scientific Reports · doi:10.1038/srep10726 · Cited by 126
Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging
Schnitzer (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s11677 · Cited by 125
Zhang, Y., Schwerbrock, N. M. J., Rogers, A. B., Kim, W. Y., & Huang, L. (2013) · Molecular Therapy · doi:10.1038/mt.2013.120 · Cited by 122
Saravanakumar, G., Lee, J., Kim, J., & Kim, W. J. (2015) · Chemical Communications · doi:10.1039/c5cc01937k · Cited by 120
Lv, L., Liu, C., Chen, C., Yu, X., Chen, G., Shi, Y., Qin, F., Ou, J., Qiu, K., & Li, G. (2016) · Oncotarget · doi:10.18632/oncotarget.8607 · Cited by 118
Ding, Y., Su, S., Zhang, R., Shao, L., Zhang, Y., Wang, B., Li, Y., Chen, L., Yu, Q., Wu, Y. F., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.053 · Cited by 118
Yue, C., Yang, Y., Song, J., Alfranca, G., Zhang, C., Zhang, Q., Yin, T., Pan, F., de la Fuente, J. M., & Cui, D. (2017) · Nanoscale · doi:10.1039/c7nr02193c · Cited by 115
The effect of photodynamic therapy on tumor angiogenesis
Ramaswamy, B., Gan, Y. Y., Soo, K. C., & Olivo, M. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0016-4 · Cited by 113
Recent advances in near-infrared light-responsive nanocarriers for cancer therapy
Saneja, A., Kumar, R., Arora, D., Kumar, S., Panda, A. K., & Jaglan, S. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.02.005 · Cited by 111
Hu, M., Huang, P., Wang, Y., Su, Y., Zhou, L., Zhu, X., & Yan, D. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00513 · Cited by 106
Carbon nanotubes-liposomes conjugate as a platform for drug delivery into cells
Karchemsky, F., Zucker, D., Barenholz, Y., & Regev, O. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.037 · Cited by 103
Current status of liposomal porphyrinoid photosensitizers
Skupin-Mrugalska, P., Piskorz, J., Gośliński, T. A., Mielcarek, J., Konopka, K., & Düzgüneş, N. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.04.003 · Cited by 103
Yang, Z., Sun, N., Cheng, R., Zhao, C., Liu, J., & Tian, Z. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb01510k · Cited by 102
Self-citationZhou, J., Li, P., Xue, X., He, S., Kuang, Y., Zhao, H., Chen, S., Zhi, Q., & Guo, X. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.07.022 · Cited by 101
Systemic Delivery of microRNA‐34a for Cancer Stem Cell Therapy
Shi, S., Han, L., Gong, T., Zhang, Z., & Sun, X. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201208077 · Cited by 100
Zhao, P., Zheng, M., Luo, Z., et al. (2015) · Scientific Reports · doi:10.1038/srep14258 · Cited by 100
Chen, T., Wang, C., Liu, Q., Meng, Q., Sun, H., Huo, X., Sun, P., Peng, J., Liu, Z., Yang, X., et al. (2014) · Cancer Biology & Therapy · doi:10.4161/15384047.2014.987062 · Cited by 98
Liu, J., Meng, T., Ming, Y., Wen, L., Cheng, B., Liu, N., Huang, X., Hong, Y. K., Yuan, H., & Hu, F. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s111647 · Cited by 98
Cheng, L., Kamkaew, A., Sun, H., Jiang, D., Valdovinos, H. F., Gong, H., England, C. G., Goel, S., Barnhart, T. E., & Cai, W. (2016) · ACS Nano · doi:10.1021/acsnano.6b03074 · Cited by 96
Tian, L., Chen, Q., Yi, X., Wang, G., Chen, J., Ning, P., Yang, K., & Liu, Z. (2017) · Theranostics · doi:10.7150/thno.17381 · Cited by 96
Xi, J., Da, L., Yang, C., Chen, R., Gao, L., Fan, L., & Han, J. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s132270 · Cited by 96
Chen, F., Zhao, Y., Pan, Y., Xue, X., Zhang, X., Kumar, A., & Liang, X. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500744m · Cited by 90
Elgqvist, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051102 · Cited by 90
Deng, L., Cai, X., Sheng, D., Yang, Y., Strohm, E. M., Wang, Z., Ran, H., Wang, D., Zheng, Y., Li, P., et al. (2017) · Theranostics · doi:10.7150/thno.21283 · Cited by 90
Photothermo-chemotherapy of cancer employing drug leakage-free gold nanoshells
Wang, L., Yuan, Y., Lin, S., Huang, J., Dai, J., Jiang, Q. Y., Cheng, D., & Shuai, X. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.11.024 · Cited by 89
Liang, X., Shi, B., Wang, K., Fan, M., Jiao, D., Ao, J., Song, N., Wang, C., Gu, J., & Li, Z. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.12.015 · Cited by 89
Teng, I., Chang, Y. M., Wang, L., Lu, H.-Y., Wu, L.-C., Yang, C., Chiu, C., Yang, C.-H., Hsu, S., & Ho, J. A. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.06.001 · Cited by 88
Au, K. M., Min, Y., Tian, X., Zhang, L., Perello, V., Caster, J. M., & Wang, A. Z. (2015) · ACS Nano · doi:10.1021/acsnano.5b02913 · Cited by 85
Synergistic Cytotoxicity of Irinotecan and Cisplatin in Dual-Drug Targeted Polymeric Nanoparticles
Valencia, P. M., Pridgen, E. M., Perea, B., Gadde, S., Sweeney, C. J., Kantoff, P. W., Bander, N. H., Lippard, S. J., Langer, R., Karnik, R., et al. (2012) · Nanomedicine · doi:10.2217/nnm.12.134 · Cited by 83
Kucińska, M., Skupin-Mrugalska, P., Szczołko, W., Sobotta, Ł., Sciepura, M., Tykarska, E., Wierzchowski, M., Teubert, A., Fedoruk‐Wyszomirska, A., Wyszko, E., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00052 · Cited by 82
Kim, C., Shah, B. P., Subramaniam, P., & Lee, K. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100460h · Cited by 81
Habiba, K., Encarnación-Rosado, J., García-Pabón, K., Villalobos‐Santos, J. C., Makarov, V. I., Avalos, J. A., Weiner, B. R., & Morell, G. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s95440 · Cited by 81
Zhang, T., Huang, P., Shi, L., Su, Y., Zhou, L., Zhu, X., & Yan, D. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00005 · Cited by 81
Liu, K., Chen, W., Yang, T., et al. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s147028 · Cited by 80
Tian, Y., & Mao, S. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.681299 · Cited by 78
Kinoh, H., Miura, Y., Chida, T., Liu, X., Mizuno, K., Fukushima, S., Morodomi, Y., Nishiyama, N., Cabral, H., & Kataoka, K. (2016) · ACS Nano · doi:10.1021/acsnano.6b00900 · Cited by 76
Liu, Y., Wan, G., Guo, H., Liu, Y., Zhou, P., Wang, H., Wang, D., Zhang, S., Wang, Y., & Zhang, N. (2017) · Nano Research · doi:10.1007/s12274-016-1339-8 · Cited by 76
Cao, M., Wang, P., Kou, Y., Wang, J., Liu, J., Li, Y., Li, J., Wang, L., & Chen, C. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b06938 · Cited by 75
Długaszewska, J., Szczołko, W., Koczorowski, T., Skupin-Mrugalska, P., Teubert, A., Konopka, K., Kucińska, M., Murias, M., Düzgüneş, N., Mielcarek, J., et al. (2017) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2017.04.009 · Cited by 75
Nanocarrier‐Mediated Photochemotherapy and Photoradiotherapy
Denkova, A. G., de Kruijff, R. M., & Serra‐Crespo, P. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201701211 · Cited by 75
Jardim, G. A. M., Lima, D. J. B., Valença, W. O., Lima, D. J. B., Cavalcanti, B. C., Pessoa, C., Rafique, J., Braga, A. L., Jacob, C., Júnior, E. N. D. S., et al. (2017) · Molecules · doi:10.3390/molecules23010083 · Cited by 73
Abbasi, M., Lavasanifar, A., & Uludaˇ, H. (2011) · Medicinal Research Reviews · doi:10.1002/med.20244 · Cited by 71
Park, J. K., Jung, J., Subramaniam, P., Shah, B. P., Kim, C., Lee, J. K., Cho, J., Lee, C., & Lee, K. (2011) · Small · doi:10.1002/smll.201100012 · Cited by 70
A Promising Road with Challenges: Where Are Gold Nanoparticles in Translational Research?
Bao, C., Conde, J., Polo, E., del Pino, P., Moros, M., Baptista, P. V., Grazú, V., Cui, D., & de la Fuente, J. M. (2014) · Nanomedicine · doi:10.2217/nnm.14.155 · Cited by 69
Li, J., Yin, T., Wang, L., Yin, L., Zhou, J., & Huo, M. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.02.002 · Cited by 68
Karageorgis, A., Dufort, S., Sancey, L., Henry, M., Hirsjärvi, S., Passirani, C., Benoît, J., Gravier, J., Texier, I., Montigon, O., et al. (2016) · Scientific Reports · doi:10.1038/srep21417 · Cited by 68
DNA nanotechnology: a future perspective
Zahid, M., Kim, B., Hussain, R., Amin, R., & Park, S. H. (2013) · Nanoscale Research Letters · doi:10.1186/1556-276x-8-119 · Cited by 67
Zhu, J., Zhao, L., Cheng, Y., Xiong, Z., Tang, Y., Shen, M., Zhao, J., & Shi, X. (2015) · Nanoscale · doi:10.1039/c5nr05585g · Cited by 66
Tian, Y., Shi, C., Sun, Y., Zhu, C., Sun, C. C., & Mao, S. (2015) · Molecular Pharmaceutics · doi:10.1021/mp5006504 · Cited by 64
Minami-Shimmyo, Y., Ohe, Y., Yamamoto, S., Sumi, M., Nokihara, H., Horinouchi, H., Yamamoto, N., Sekine, I., Kubota, K., & Tamura, T. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31823c4c07 · Cited by 63
Dong, D., Gao, W., Liu, Y., & Qi, X. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.01.011 · Cited by 63
Zhu, W.-J., Yang, S.-D., Qu, C., Zhu, Q., Chen, W.-L., Li, F., Yuan, Z.-Q., Liu, Y., You, B., & Zhang, X. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s126310 · Cited by 62
Zhu, Y., Sun, Y., Chen, Y., Liu, W., Jiang, J., Guan, W., Zhang, Z., & Duan, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16059573 · Cited by 60
Krishnamurthy, S., Ng, V. W. L., Gao, S., Tan, M., & Yang, Y. Y. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.07.018 · Cited by 60
Kim, K. S., Park, W., & Na, K. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.09.014 · Cited by 59
Wang, S., Liu, S., Zhao, B., Yang, F., Wang, Y.-T., Liang, Q., Sun, Y., Liu, Y., Song, Z., Cai, Y., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4536 · Cited by 59
Rui, M., Qu, Y., Gao, T., Ge, Y., Feng, C., & Xu, X. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s122171 · Cited by 55
Polysaccharide nano-vesicular multidrug carriers for synergistic killing of cancer cells
Pramod, P. S., Shah, R., Chaphekar, S., Balasubramanian, N., & Jayakannan, M. (2014) · Nanoscale · doi:10.1039/c4nr03514c · Cited by 54
Nanoparticles for Effective Combination Therapy of Cancer
Jadia, R., Scandore, C., & Rai, P. (2016) · International Journal of Nanotechnology and Nanomedicine · doi:10.33140/ijnn/01/01/00003 · Cited by 54
Charest, G., Sanche, L., Fortin, D., Mathieu, D., & Paquette, B. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.10.054 · Cited by 53
Katragadda, U., Fan, W. Q., Wang, Y., Teng, Q., & Tan, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058619 · Cited by 52
Zhang, Y. J., Gallis, B. M., Taya, M. D., Wang, S., Ho, R. J. Y., & Sasaki, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059086 · Cited by 51
Tsai, H., Maryani, F., Huang, C., Imae, T., & Lin, J.-Y. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s53636 · Cited by 49
Cited by
Clinical development and potential of photothermal and photodynamic therapies for cancer
Li, X., Lovell, J. F., Yoon, J., & Chen, X. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0410-2 · Cited by 3,456
Nanomaterials for cancer therapy: current progress and perspectives
Cheng, Z., Li, M., Dey, R., & Chen, Y. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01096-0 · Cited by 1,168
Chehelgerdi, M., Chehelgerdi, M., Allela, O. Q. B., Pecho, R. D. C., Jayasankar, N., Rao, D. P., Thamaraikani, T., Vasanthan, M., Viktor, P., Lakshmaiya, N., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01865-0 · Cited by 1,062
Nanoparticle Surface Functionalization: How to Improve Biocompatibility and Cellular Internalization
Sanità, G., Carrese, B., & Lamberti, A. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.587012 · Cited by 765
Gunaydin, G., Gedik, M. E., & Ayan, S. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.686303 · Cited by 402
Metadata
- Authors
- Zhao, C.-Y., Cheng, R., Yang, Z., & Tian, Z.-M.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2018-04-04
- Volume
- 23
- Issue
- 4
- Pages
- 826
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2796117568
- Cited by
- 330
- References
- 225
- FWCI
- 9.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.